dc.date.accessioned2023-04-16T04:38:15Z
dc.date.accessioned2023-05-23T18:56:48Z
dc.date.available2023-04-16T04:38:15Z
dc.date.available2023-05-23T18:56:48Z
dc.date.created2023-04-16T04:38:15Z
dc.date.issued2023
dc.identifierhttps://hdl.handle.net/20.500.12866/13391
dc.identifierhttps://doi.org/10.21769/BioProtoc.4621
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6395862
dc.description.abstractMalaria molecular surveillance has great potential to support national malaria control programs (NMCPs), informing policy for its control and elimination. Here, we present a new three-day workflow for targeted resequencing of markers in 13 resistance-associated genes, histidine rich protein 2 and 3 (hrp2&3), a country (Peru)-specific 28 SNP-barcode for population genetic analysis, and apical membrane antigen 1 (ama1), using Illumina short-read sequencing technology. The assay applies a multiplex PCR approach to amplify all genomic regions of interest in a rapid and easily standardizable procedure and allows simultaneous amplification of a high number of targets at once, therefore having great potential for implementation into routine surveillance practice by NMCPs. The assay can be performed on routinely collected filter paper blood spots and can be easily adapted to different regions to investigate either regional trends or in-country epidemiological changes.
dc.languageeng
dc.publisherBio-Protocol
dc.relationBio-protocol
dc.relation2331-8325
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPlasmodium falciparum
dc.subjectAmpliSeq custom assay
dc.subjectDrug resistance
dc.subjectMalaria
dc.subjectMolecular surveillance
dc.subjectSequencing
dc.titleMolecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Plasmodium falciparum Parasites from Dried Blood Spot DNA Isolates from Peru.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución